Dopamine transporter density may be associated with the depressed affect in healthy subjects

Nuclear Medicine Communications

Volumn 28, Issue 1, 2007, Pages 3-6

  Newberg, Andrew ^a,b   Amsterdam, Jay ^b   Shults, Justine ^a  

^a Psychiatry   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Affect; Depression; Dopamine transporter; Mood; SPECT

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; AMFEBUTAMONE; AMINEPTINE; BROMOCRIPTINE; DOPAMINE TRANSPORTER; NOMIFENSINE; PHENYLALANINE DERIVATIVE; PIRIBEDIL; PRAMIPEXOLE; SELEGILINE; TRANYLCYPROMINE; YKP 10A;

ADULT; ARTICLE; BASAL GANGLION; BINDING AFFINITY; CAUDATE NUCLEUS; CORPUS STRIATUM; DEPRESSION; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MOOD; NEUROTRANSMISSION; NORMAL HUMAN; PROFILE OF MOOD STATES; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BRAIN; DEPRESSIVE DISORDER, MAJOR; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIGANDS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PUTAMEN; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 33845641617     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328013dc9d     Document Type: Article

References (29)

1. Randrup A, Munkvad I, Fog R. Mania, depression and brain dopamine. In: Essman WB, Valzelli L, editors. Current developments in psychopharmacology, Vol. 2. New York: Spectrum Press; 1975. pp. 206-248.
2. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 1997; 134:319-329.
3. Cabib S, Giardino L, Calza L, Zanni M, Mele A, Puglisi-Allegra S. Stress promotes major changes in dopamine receptor densities within the mesoaccumbens and nigrostriatal systems. Neuroscience 1998; 84:193-200.
4. Cabib S, Puglisi-Allegra S. Stress, depression and the mesolimbic dopamine system. Psychopharmacology 1996; 128:331-342.
5. Gambarana C, Masi F, Tagliamonte A, Scheggi S, Ghiglieri O, De Montis MG. A chronic stress that impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study. J Neurochem 1999; 72:2039-2046.
6. Willner P. Dopaminergic mechanisms in depression and mania: In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: The fourth generation of progress. New York: Raven Press; 1995.
7. Bowden C, Cheetham SC, Lowther S, Katona CLE, Crompton MR, Horton RW. Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Res 1997; 769:135-140.
8. Roy A, Pickar D, Linnoila M, Doran AR, Ninan P, Paul SM. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia. Psychiat Res 1985; 15:281-292.
9. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press; 1990.
10. Goeders NE, Smith JE. Cortical dopaminergic involvement in cocaine reinforcement. Science 1983; 221:773-775.
11. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Ding YS, Logan J, et al. Relationship between psychostimulant-induced ‘high’ and dopamine transporter occupancy. Proc Natl Acad Sci USA 1996; 93:10388-10392.
12. Amsterdam JD, Brunswick DJ, Hundert M. A single-site, double-blind, placebo-controlled, dose ranging study of YKP10A - a putative, new antidepressant. Prog Neuro-Psychopharmacol Biol Psychiat 2002; 26:1333-1338.
13. Goldberg JF, Frye MA, Dunn RT. Pramipexole in refractory bipolar depression. Am J Psychiat 1999; 156:798.
14. Pacheco MA, Copeland N, James S, Goodhead ML, Kato G, Wecker L. Effects of the selegiline transdermal system on CNS receptors and MAO activities in brain and intestine. FASEB J 2000; 14:A-1995.
15. Gordon R, Bernard P, Pack E, Lee K, Choi YM. Pharmacological profile of YKP10A: a novel antidepressant. Soc Neurosci Abs 1998; 583: 24.
16. Byrum CE, Ahearn EP, Krishnan KR. A neuroanatomic model for depression. Prog Neuro-Psychopharmacol Biol Psychiat 1999; 23:175-193.
17. Rogers MA, Bradshaw JL, Pantelis C, Phillips JG. Frontostriatal deficits in unipolar major depression. Brain Res Bull 1998; 47:297-310.
18. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and methamphetamine in mice lacking the dopamine transporter. Nature 1996; 379:606-612.
19. Jaber M, Jones S, Giros B, Caron MG. The dopamine transporter: a crucial component regulating dopamine transmission. Movement Disord 1997; 12:629-633.
20. Mozley PD, Stubbs JB, Plossl K, Dresel SH, Barraclough ED, Alavi A, et al. Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters. J Nucl Med 1999; 39:2069-2076.
21. Mozley LH, Gur RC, Mozley PD, Gur RE. Striatal dopamine transporters and cognitive functioning in healthy men and women. Am J Psychiat 2001; 158:1492-1499.
22. 99mTc]TRODAT-1 increased brain dopamine transporter availability in major depression. Am J Psychiat 2003; 160:1836-1841.
23. McNair DM, Lorr M, Droppleman LF. EdITS manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1992.
24. McNair DM, Lorr M, Droppleman LF. Manual for the profile of mood states. San Diego, CA: Educational and Industrial Testing Service; 1971.
25. 99mTc]TRODAT-1 and single-photon emission tomography. Eur J Nucl Med 2000; 27:1714-1718.
26. Mozley PD, Acton PD, Barraclough ED, Plossl K, Gur RC, Alavi A, et al. Effects of age on dopamine transporters in healthy humans. J Nucl Med 1999; 40:1812-1817.
27. Laasonen-Balk T, Kuikka J, Viinamaki H, Husso-Saastamoinen M, Lehtonen J, Tiihonen J. Striatal dopamine transporter density in major depression. Psychopharmacology 1999; 144:282-285.
28. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiat 1998; 44:1090-1098.
29. Gardiner SA, Morrison MF, Mozley PD, Mozley LH, Brensinger C, Bilker W, et al. Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women. Am J Ger Psychiat 2004; 12:621-630.